Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesResearch & DevelopmentShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intelligent Bio Solutions (INBS) Operating Expenses (2019 - 2025)

Intelligent Bio Solutions has reported Operating Expenses over the past 6 years, most recently at $750094.0 for Q2 2024.

  • For Q2 2024, Operating Expenses fell 73.13% year-over-year to $750094.0; the TTM value through Jun 2024 reached $9.2 million, down 32.8%, while the annual FY2024 figure was $1.7 million, 87.64% down from the prior year.
  • Operating Expenses for Q2 2024 was $750094.0 at Intelligent Bio Solutions, down from $3.2 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $6.7 million in Q1 2023 and troughed at $27291.0 in Q1 2020.
  • A 5-year average of $2.2 million and a median of $2.2 million in 2022 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: surged 11533.16% in 2021 and later tumbled 73.13% in 2024.
  • Year by year, Operating Expenses stood at $1.2 million in 2020, then skyrocketed by 203.61% to $3.6 million in 2021, then dropped by 27.43% to $2.6 million in 2022, then fell by 11.37% to $2.3 million in 2023, then tumbled by 68.0% to $750094.0 in 2024.
  • Business Quant data shows Operating Expenses for INBS at $750094.0 in Q2 2024, $3.2 million in Q1 2024, and $2.3 million in Q4 2023.